News & Updates

Psilocybin shows therapeutic potential for depression
Psilocybin shows therapeutic potential for depression
24 Apr 2023

For cancer patients with depression, treatment with a single dose of psilocybin appears to yield rapid and meaningful improvements in depressive symptoms, as shown in a phase II study.

Psilocybin shows therapeutic potential for depression
24 Apr 2023
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae
22 Apr 2023 byElvira Manzano

Sleep disruption following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness in the CircCOVID cohort sub-study presented at ECCMID 2023.

Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae
22 Apr 2023
Biofeedback-virtual reality device beneficial in chronic migraine
Biofeedback-virtual reality device beneficial in chronic migraine
18 Apr 2023

For individuals with chronic migraine, frequent use of a portable biofeedback-virtual reality device leads to a decreased frequency of acute analgesic drug use and an improvement in depression, as shown in a pilot study.

Biofeedback-virtual reality device beneficial in chronic migraine
18 Apr 2023